EN
HI
Summary
As of 27 Oct, 2026, Zydus Lifesciences stock price is ₹1160.4. During the trading session, the stock has moved between an intraday low of ₹1093.50 and an intraday high of ₹1160.40. Over the last 52 weeks, Zydus Lifesciences has traded between ₹835.50 and ₹1232.10.
The stock has recorded a trading volume of 24,28,387 shares,. Its Average Traded Price (ATP) is ₹1139.78, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1160.40.
Zydus Lifesciences has an upper circuit limit of ₹1242.30 and a lower circuit limit of ₹1016.50. The total value traded stands at ₹276.78 CR, and the delivery percentage for the day is 52.08%.
The stock is currently traded with a market lot size of 1. Zydus Lifesciences also offers a dividend yield of 0.09%.
Zydus Lifesciences Share Price Chart
Zydus Lifesciences Share Key Metrics
Volume
24.28 L
Market Cap
115750.34 CR
LTQ@LTP
1@1160.40
ATP
1139.78
Var Margin
13.19 %
Circuit Range
1016.5-1242.3
Delivery %
52.08 %
Value
276.78 CR
ASM/GSM
No
Market Lot
1
Zydus Lifesciences Fundamentals
P/E Ratio
24.93
P/B Ratio
4.17
Div. Yield
0.09
Sector P/E
37.75
Sector P/B
3.1
Sec. Div. Yield
0.54
Zydus Lifesciences Resistance and Support
Pivot 1130.6
Resistance
First Resistance
1142.3
Second Resistance
1155.2
Third Resistance
1166.9
Support
First Support
1117.7
Second Support
1106
Third Support
1093.1
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
27OCT26
1162.60
34.30 (3.04%)
23NOV26
1168.80
36.70 (3.24%)
29DEC26
1172.00
35.20 (3.10%)
ZYDUSLIFE|27OCT26 CE 1160.00
8.75
6.4 (272.34%)
ZYDUSLIFE|27OCT26 PE 1170.00
12.25
-30.85 (-71.58%)
Zydus Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 26 2026 | 1129.4 | 1160.4 | 2.74% | 1160.4 | 1093.5 |
| Fri Oct 23 2026 | 1138 | 1129.4 | -0.49% | 1143.5 | 1118.9 |
| Thu Oct 22 2026 | 1116 | 1135 | 1.58% | 1138.5 | 1100.3 |
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Lifesciences' subsidiary Zylidac Bio has partnered with Prolific Machines to scale its next-generation biologics manufacturing platform. The partnership will transition from early development to commercial GMP production, starting with a tech transfer at the 50-liter scale.
Oct 21 2026 18:27:52
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus received final USFDA approval for Estradiol and Levonorgestrel Transdermal System. The drug targets an annual US market size of $45.7 million and is eligible for 180-day CGT exclusivity.
Oct 21 2026 11:12:24
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Sun Pharmaceutical Industries Ltd.
1740.00
-8.00 (0.46%)
Divi's Laboratories Ltd.
9050.00
100.00 (1.12%)
Torrent Pharmaceuticals Ltd.
4550.00
25.60 (0.57%)
Lenskart Solutions Ltd.
651.20
24.75 (3.95%)
Apollo Hospitals Enterprise Ltd.
7844.00
114.00 (1.47%)
Laurus Labs Ltd.
2058.90
88.90 (4.51%)
Cipla Ltd.
1355.00
17.00 (1.27%)
Dr. Reddy's Laboratories Ltd.
1310.90
81.40 (6.62%)
Mankind Pharma Ltd.
2312.00
99.40 (4.49%)
Aurobindo Pharma Ltd.
1590.00
18.30 (1.16%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1160.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 24.93. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.17. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 37.75 & 3.1 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 115750.34 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1232.10 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ZYDUSLIFE
